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ABSTRACT 
Objective: The study investigated the activities of antihypoglycemic and antihypolipidemic of ethanolic roots extract of Crossopteryx febrifuga (CF) in alloxan-induced diabetic rats. 
Methods: Twenty male albino rats were randomly distributed to four groups; I, II, III and IV with each consisting of five animals received extracts as follows: Group I, C .febrifuga 
(500 mg/kg bwt); Group II, C.febrifuga (250 mg/kg bwt); Group III, C. febrifuga (100 mg/kg bwt); Group IV, 0.5 ml (2% w/v) acacia solution and served as control. After 30 min, the 
animals were each administered orally with 20% (w/v) glucose at a dose of 0.5ml /100 g bwt. Blood glucose levels were then monitored at 30, 60, and 120 min. intervals and 
reported as the average glucose level of each group. Twenty- Five (25) Albino rats were randomly divided into five (5) experimental groups: control, diabetic, standard drug 
(glibenclamide) and C. febrifuga (375 and 500 mg/kg bwt) treated diabetic groups. The animals in four out of five groups were fasted for 18 h and were made diabetic by injecting 
with a single dose of alloxan (ALX) 150 mg/kg. Blood was collected on days 0, 5, 10 and 15 for glucose estimation and day 15 for lipid profile assay. Results: A significant 
reduction in postprandial sugar level was observed after 60 min in all treatments. Alloxan-induced diabetic rats without treatment showed significant increases ( p < 0.05) in the 
levels of blood glucose, triglycerides, total cholesterol, low density lipoprotein LDL-cholesterol while the high density lipoprotein HDL-cholesterol level were significantly decreased ( 
p< 0.05) compared to normal rats. In addition, the diabetic rats treated with the CF and glibenclamide showed significant decrease ( p < 0.05) in both  blood glucose, TG and LDL-
cholesterol levels and a significant decrease ( p < 0.05) in HDL-cholesterol level compared to diabetic untreated rats. Conclusion: The ethanolic roots extract of Crossopteryx 
febrifuga (CF) possesses potential hypoglycemic and hypolipidemic activities in alloxan-induced diabetic rats. 
Keywords: Crossopteryx febrifuga, glibenclamide, alloxan, hypoglycemic, hypolipidemic, postprandial.
INTRODUCTION 
Diabetes  has  become  one  of  the  major  devastating  diseases 
afflicting health of many people, in recent times, and has accounted 
for a high proportion of health problems worldwide [1]. It affects at 
least  15  million  people  and  having  complications  which  include 
hypertension, atherosclerosis and microcirculatory disorders [2].It is 
also  associated  with  the  long  term  complications,  including 
retinopathy, nephropathy, neuropathy and angiopathy [3]. Managing 
blood sugar levels and keeping it closer to normal values is able to 
reduce  the  risk  of  diabetes  and  death  by  these  complications. 
Impaired  carbohydrate  and  protein  utilization  in  the  diabetic  also 
leads  to  accelerated  lipolysis,  which  results  in  elevated  plasma 
triglycerides levels [4]. 
To  reduce  the  risk  of  vascular  complications  in  diabetes  mellitus, 
control  not  only  of  blood  glucose  levels  but  also  lipid  levels  and 
weight are necessary [5]. 
Although  treatment  of  diabetes  with  insulin  and  many  oral 
hypoglycaemic  agents  has  recorded  huge  successes,  they  were 
however,  associated  with  some  serious  side  effects  like  recurrent 
cases of hypoglycemic coma and obesity [6]. 
Moreover,  these  orthodox  medications  seem  to  be  insufficient  to 
prevent diabetic complications. These  limitations to  a large  extent 
accounted for drift towards alternative therapies that include herbal 
formulations  [7].  Plant  products  have  been  long  used  in  the 
treatment of diabetic patients through improving the diabetic status 
in terms of blood sugar [8, 9, 10]. For these vital reasons, therefore, 
there is an urgent need for a search for cheap and safe blood sugar 
lowering  oral hypoglycaemic  agents that  would be  effective in the 
treatment of diabetes and lack of serious side effects of the currently 
used oral hypoglycemic agents.  
Crossopteryx febrifuga belongs to Rubiaceae Family, It is a twisted 
tree  with  conspicuous  tubular  flowers,  which  is  widely  distributed 
throughout  the  Savannah region  of West  and Tropical Africa. It  is 
commonly found in all part of Nigeria and known as Ayeye among 
yorubas in Nigeria. It is used traditionally for symptomatic relief of 
dry  cough  and  for  treatment  of  respiratory  infections,  fever, 
dysentery  and  pain  [11].  In  northern  Nigeria,  the  plant  has  been 
used for treatment of pain and malaria [12]. It has been reported that 
the  crude  methanolic  extract  of  C.  febrifuga  contains  biologically 
active  substances  with  potential  values  in  the  treatment  of 
trypanosomiasis, malaria, Staph aureus infection [13, 14]. [15] have 
reported that the extract possesses analgesic, antipyretic and anti-
inflammatory  activities. [16]  has  also reported the  gastroprotective 
effect  of the  plant. There  are claims  by some herbal practitioners 
that aqueous roots extract of Crossopteryx febrifuga is effective in 
the  management  of  DM  and  diabetic  complications.  The  scientific 
evidence to back this claim is lacking. In view of this, the study was 
aimed  at  the  evaluation  of  the  hypoglycemic  and  hypolipidemic 
effects  of  ethanolic  roots  extract  of  Crossopteryx  febrifuga  in 
alloxan-induced diabetic rats. 
MATERIALS AND METHOD 
PLANT MATERIAL 
Collection of Plant material 
Crossopteryx febrifuga (CF) was collected from cultivated farmland 
at  Ojokoro,  Ifako-Ijaiye,  Lagos  State,  Nigeria,  in  the  month  of 
November, 2012. The plant  was identified  and  authenticated by  a 
botanist,  Prof.  J.  Dele  Olowokudejo  of  Botany  department  of 
University  of  Lagos,  Nigeria,  where  voucher  specimen  has  been 
deposited in the herbarium. 
 Ojewale et al                                                                                                                  Mintage journal of Pharmaceutical & Medical Sciencesǀ 
Vol 2 Issue 3, July – Sep 2013                                                                                                                                                                                       2 
  
Preparation of plant extract 
The roots of the plant were shade-dried at room temperature for 7 
days and then powdered using mortar and pestle. The root powder 
1150 g was soaked with 96% aqueous alcohol in three cycles using 
soxhlet extractor. The crude extract was filtered with Whitman filter 
paper  4,  and  the  filtrate  was  concentrated  and  dried  in  a  rotary 
vacuum  evaporator  under  reduced  pressure  in  vacuole  30
0C  to 
obtain 108.2g dry residue to yield an (9.41% vol.) viscous brownish-
coloured  extract  which  was  stored  in  an  air  tight  bottle  kept  in  a 
refrigerator at 4
0C till used. 
Experimental Animals 
Forty  five  healthy  male  albino  rats  weighing  between  170-200  g 
were  obtained  from  the  Laboratory  Animal  Center  of  College  of 
Medicine,  University  of  Ibadan,  Ibadan,  Nigeria.  The  rats  were 
housed in clean cages with the filter tops under controlled conditions 
of 12 h light/dark cycle, 50% humidity at 26±2
0C and kept in a well-
ventilated  room  and  allowed  to  acclimatize  to  the  laboratory 
condition for two week before being used. They were maintained on 
a  standard  animal  pellet  (CHI  Feeds  Plc.,  Nigeria)  and  had  free 
access to water ad libitum. The animals were distributed randomly 
into four groups of five animals each for postprandial study and into 
four  groups  of  five  rats  each  for  the  alloxan-induced  diabetic 
experiment  and  the  fifth  group  consists  of  5  rats  served  as  the 
control (normal) group.  
Acute Toxicity Studies 
The  acute  toxicity  of  ethanolic  roots  extract  of  Crossopteryx 
febrifuga were determined by using thirty-five (35) male Swiss albino 
mice weighing between 20-22.5 g, which were maintained under the 
standard conditions. The animals were randomly distributed into a 
control  group  and  six  treated  groups,  containing  five  animals  per 
group. After depriving them food with 12 h prior to the experiment 
with access to water only, the control group was administered with 
single dose of ethanolic roots extract of Crossopteryx febrifuga with 
at a dose of 0.3ml of 2% Acacia solution orally while each treated 
group was administered with single dose of ethanolic roots extract of 
Crossopteryx febrifuga orally with at a doses of 1.0, 2.5, 5.0, 10, 15 
and 20.0g/kg body weight respectively of 2% acacia solution. They 
were closely  observed  in the first 4 hours and then hourly for the 
next 12 hours followed by hourly intervals for the next 56 hours and 
continued  for  the  next  2weeks  after  the  drug  administration  to 
observe  any  death  or  changes  in  behaviour,  economical, 
neurological profiles and other physiological activities [17, 18].  
Postprandial Test 
Twenty albino rats were randomly distributed to four groups; A, B, C 
and D with each consisting of five animals. There were only fasted 
for  about 18hrs  prior  to  the  experiment  with  access to  water  only 
[19].  Glucometer  (Accu-Chek,  Roche  Diagnostics)  was  used  to 
estimate their initial blood sugar level. The extracts suspension was 
respectively prepared by dispersing 3.75 g of the extract dissolved in 
25 ml acacia (2% W/V), solution. 
The animals were treated as follows: 
Group I received Crossopteryx febrifuga (500 mg/kg b wt) 
Group II received Crossopteryx febrifuga (250 mg/kg b wt) 
Group III received Crossopteryx febrifuga (100 mg/kg b wt) 
Group IV received 0.5ml (2% W/V) acacia solution  and served  as 
control. 
After 30min,  each  animal  was  administered  orally  with  20% (W/V) 
glucose  at  a  dose  of  0.5ml/100g  bwt.  Blood  glucose  levels  were 
monitored  at  30,  60  and  120  min  intervals  and  reported  as  the 
average  glucose  level  of  each  group  intervals  after  post  glucose 
challenge.  
Experimental Design 
Diabetes was induced by intraperitoneal (ip) injection of alloxan (150 
mg/kg body weight) dissolved in 3ml of normal saline [20]. After 72 h 
blood was taken from the lateral veins of the tail and the blood sugar 
levels  were  monitored  with  a  glucometer  (ACCUCHEK,  Roche 
Diagnostics)  for  estimation  blood  sugar  level.  The  animals  with 
blood sugar level more than 200 mg/dl [21] were considered diabetic 
and included in the experiment. 
The diabetic animals were randomly distributed into four groups of 
five animals each while the last group, the positive control, consists 
of five normal rats and were treated as follows: 
Group I:    Normal rats (positive control). 
Group II:  ALX- induced diabetic animals but untreated to serve as  
negative control. 
Group  III:  ALX-  induced  diabetic  treated  with  Glibenclamide  (10 
mg/kg b wt) 
Group IV: ALX- induced diabetic treated with Crossopteryx febrifuga 
extract (375 mg/kg b wt) 
Group V:  ALX- induced diabetic treated with Crossopteryx febrifuga 
extract (500 mg/kg b wt) 
Evaluation of Hypoglycaemic and Hypolipidaemic Effects 
The  animals  were  treated  daily  for  fifteen  days.  On  the  15th  day 
after treatment they  were starved  overnight,  and  on the 16th day, 
they were anaesthetized with diethyl ether and blood obtained via 
cardiac  puncture  into  heparinized  container.  The  blood  was 
centrifuged within 5 min of collection at 5000rpm to obtain plasma 
which  was  analyzed  for  glucose  level,  total  cholesterol,  total 
triglyceride,  HDL-cholesterol  levels  by  precipitation  and  modified 
enzymatic procedures from Sigma Diagnostics [22]. LDL-cholesterol 
levels were calculated using Friedwald equation [23].  
Statistical Analysis 
Data  is  reported  as  Mean  ±  SD.  Statistical  comparisons  were 
determined  by  analysis  of  variance  (ANOVA)  and  means  were 
separated using Duncan’s multiple range test (p < 0.05). 
RESULTS  
Acute Toxicity 
The acute toxicity study result (Table 1), showed that five out of the 
five animals that received 20.0 g/kg body weight of the extract died 
within  4  h  (100  %  death)  while    one  out  of  the  five  animals  that 
received 1 g/kg body weight of the extract died within 24 h (20%). 
The oral route of LD50 of the drug was found to be from 1.0- 2.5 g/kg 
b wt. The median lethal dose is therefore calculated from the graph 
to  be  1.85  g/kg  bwt.  The  LD50  of  the  extract  was  determined  by 
plotting a graph of probit on the Y-axis against the log dose on the 
X-axis. 
Table 1: Acute Toxicity Study of Ethanolic Roots Extract of 
Crossopteryx Febrifuga on Mices 
Groups  Dose 
g/kg 
Log 
dose 
24hr 
Motility 
% 
Motility 
Probit  Probit 
Approx            
    I  1.0  3.000  1/5  20  4.158  4.2 
   II  2.5  3.397  2/5  40  4.746  4.7 
   III  5.0  3.699  4/5  80  5.841  5.8 
   IV  10.0  4.000  5/5  100  8.719  8.7 
   V  15.0  4.176  5/5  100  8.719  8.7 
   VI  20.0  4.301  5/5  100  8.719  8.7 
Control group received 0.3ml each of 2% Acacia solution. 
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Effect on Body Weights 
The animals (Table 2) showed decrease in appetite and weight loss 
after  alloxan  induction.  In  the  diabetic  untreated  group,  exhibited 
progressive  weight decrease  occurred  while  in the  ethanolic roots 
extract of Crossopteryx febrifuga /glibenclamide treated, there was 
slight  weight  appreciation  after  few  days  of  treatment  with  the 
ethanolic roots extract  of Crossopteryx febrifuga /glibenclamide  as 
well as showed increased in appetite.  
Table 2: Weight Variations  
Groups   Day 1  Day 5   Day 10  Day 15 
   I   165.6±0.8    170.4±1.0   172.2±1.2   178.7±1.5 
   II   172.8±1.5    164.6±1.3   157.2±1.7   142.9±1.0 
   III   175.2±2.2    178.2±2.3   184.5±2.8   198.5±1.7 
   IV   172.4±1.1    173.6±0.9   175.2±1.2   176.1±1.3 
   V   175.4±1.4    176.8±1.5   178.6±1.1   180.4±1.6 
Mean + SD, n = 5, *P 0.05 vs control group 
 
Effect of the Extract on Postprandial Study   
The postprandial test result (Table III) showed a significant decrease 
(p < 0.05) in blood glucose levels in all treated groups after 60min of 
oral glucose administration compared to the control. The extract was 
observed to be active in lowering the postprandial the blood glucose 
level (Table 3). 
Table 3: Postprandial Test 
Groups      0 min  30 min  60 min  120 min 
I  89±6.8*  105±10.6*  93.0±4.1*  94.2±6.3* 
II  90±4.3*  108±5.9*  96±4.7*  97±7.1* 
III  88±9.7*  109±8.2*  99±8.3*  100±6.5* 
   IV  89±5.5  108±4.8  115±6.5  118±6.0 
Values are Mean + SD, n = 5, *p  0.05 compared to control 
group. 
 
Effect of the Extract/Glibenclamide on Blood Glucose  
Table 4 showed the results of the extract and glibenclamide effects 
on the blood glucose. The plasma glucose levels of the diabetic rats 
treated with the extract and glibenclamide were significantly reduced 
(p < 0.05) compared to the diabetic control. The drug proved to have 
a better plasma glucose lowering effect than glibenclamide. 
Table 4: Effect of ethanolic roots extract of crossopteryx 
febrifuga and glibenclamide on glucose levels. 
Groups  Day 0  Day 5  Day 10  Day 15 
     I  91.4±3.8  88.5±5.8  75.8±4.5  87.3±5.6 
    II  324.2±22.7  337.6±23.5  354.4±25.2  365.7±28.5 
   III  197.3±8.5*  160.2±10.3*  122.3±8.5*  87.6±7.8* 
   IV  189.6±5.7*  147.7±6.2*  105.2±6.8*  62.4±6.4* 
    V  181.7±3.5*  136.8±5.6*  91.7±5.4*  54.8±4.7* 
Values are Mean + SD, n = 5, *p  0.05 compared to control. 
 
Effect of the Extract/Glibenclamide on Lipid Profile  
Table 5 showed a significant decrease (p < 0.05) in TCHOL, TG and 
LDL-cholesterol levels while significant increase in HDL-cholesterol 
level was observed in all diabetic animals treated with the drug or 
glibenclamide.  In  contrast,  the  untreated  diabetic  animals  showed 
significant  increase  in  both  TG  and  LDL-cholesterol  levels  and  a 
significant decrease in HDL-cholesterol level. 
 
 
Table 5: Effect of ethanolic roots extract of crossopteryx 
febrifuga on lipids levels in alloxan-induced diabetic rats. 
Groups  Total Chol  HDL  LDL  TG 
     I  64.5±1.2  35.7±1.0  10.8±3.6  47.1±1.4 
    II  66.6±3.7  19.2±0.7  58.2±6.5  125.8±1.2 
    III  42.5±1.3*  30.7±0.9*  28.6±2.7*  57.5±2.5* 
    IV  36.4±0.4*  30.5±1.2*  21.3±2.0*  32.5±0.8* 
    V  29.5±2.1*  32.5±0.4*  18.8±4.1*  22.6±1.1* 
Values are Mean + SD, n = 5, *p  0.05 compared to control. 
DISCUSSION 
Diabetes is now recognized as one of the major threat diseases and 
a  leading  cause  of  mortality  and  morbidity,  claiming  many  lives 
worldwide  over  [24].  Oral  hypoglycemic  agents  such  as 
sulphonylureas  and  biguanides  have  been  commonly  used  in  the 
management of diabetes especially type II but are with serious side 
effects.  It  has  been  observed  that  hypoglycaemic  activities  occur 
from the stimulation of pancreatic beta cells to release insulin  [25, 
26]. In addition, attention has been focused on the use of plants and 
herbal remedies believed to be safer and lack of serious side effects 
as  alternatives  in  the  management  of  DM  and  diabetic 
complications. 
The median acute toxicity value (LD50) of the drug was determined 
to  be  1.85  g/kg  bwt.  According  to  27,  28,  the  extract  can  be 
classified  as  being  slight  toxic,  since  the  LD50  by  oral  route  was 
found to be 1-2.5 g/kg which was much slight closer to WHO toxicity 
index of 2 g/kg. 
Although increase in appetite and water consumption was observed 
in the diabetic and normal animals treated with the  ethanolic roots 
extract  of crossopteryx febrifuga, there  was significant  weight loss 
by the diabetic animals without treatment.  
The significant slight weight gain observed in the diabetic animals 
treated  with  the  drug  clearly  suggested  that  the  ethanolic  roots 
extract of crossopteryx febrifuga might not have the obesity forming 
tendency,  which  is  one  of  the  undesirable  side  effects  normally 
encountered  when  treating  diabetics  with  sulphonylureas.  There 
were also no changes observed in the macroscopic examinations of 
the organs of the diabetic animals treated with the  ethanolic roots 
extract of crossopteryx febrifuga or glibenclamide while the organs 
of diabetic untreated animals showed some changes compared to 
the normal control. 
The ethanolic roots extract of crossopteryx febrifuga showed to be 
effective  in decreasing  plasma glucose levels  on the diabetic rats 
and  proved  to  have  a  better  plasma  glucose  lowering  effect  than 
glibenclamide.The  effective  lowering  of  blood  sugar  level 
demonstrated by this drug supports its local use as a hypoglycaemic 
agent. 
Lipid  inhibits  the  activity  of  the  hormone  sensitive  lipases  in 
adipose tissue and suppresses the release of free fatty acids [29]. 
In diabetic conditions,  enhanced  activity  of this  enzyme (lipase) 
increases  lipolysis  and  release  more  free  fatty  acids  into 
circulation  [30].  The  lowering  of  plasma  TC,  TG  and  LDL-
cholesterol levels and significant increase in HDL-cholesterol level 
in  the  treated  animals  clearly  demonstrated  the  presence 
hypolipidaemic  agents  in  the  ethanolic  roots  extract  of 
Crossopteryx febrifuga.  
CONCLUSION 
The  study  observed  that  the  Crossopteryx  febrifuga  have  good 
postprandial  sugar  lowering  effect  and  showed  that  the 
Crossopteryx  febrifuga  possesses  some  hypoglycaemic  and 
hypolipidaemic activities.  
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